Sumatriptan Succinate
Product Images NDC 54868-6023

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 54868-6023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of 100 mg Package Label (100mg Package Label)

Image Of 100 mg Package Label (100mg Package Label)
Packaging label for Sumatriptan Succinate 100 mg by Physicians Total Care, Inc. The label includes lot number 0000 and an expiration date labeled 01/60. It identifies the manufacturer as Penn Labs Inc., Philadelphia, PA, and features a barcode with the NDC number 54868-5978-0.*
FDA Label Image

Image Of 50 mg Package Label (50mg Package Label)

Image Of 50 mg Package Label (50mg Package Label)
Label for Sumatriptan Succinate 50 mg tablets distributed by Physicians Total Care, Inc. The label shows lot number, expiration date, manufacturer (Penn Labs Inc., Philadelphia, PA), and a barcode with associated numbers. The product strength and dosage form (50 mg tablet) are clearly indicated.*
FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
Chemical structure diagram of Sumatriptan Succinate showing the molecular arrangement of atoms and bonds within the compound.*
FDA Label Image

Image Of Figure 1 (Figure 1)

Image Of Figure 1 (Figure 1)
A line graph showing estimated probability of response over time in minutes from the first dose. The graph compares placebo and three doses of Sumatriptan Succinate (25 mg, 50 mg, 100 mg), with response probability increasing over time for all treatments but higher for the active doses compared to placebo.*
FDA Label Image

Image Of Figue 2 (Figure 2)

Image Of Figue 2 (Figure 2)
A line graph showing the estimated probability of relief of migraine over 24 hours after a dose. The graph includes curves for placebo and sumatriptan succinate at doses of 25 mg, 50 mg, and 100 mg, illustrating the increase in relief probability over time for each group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.